Cargando…

A 70% cut-off for MYC protein expression in diffuse large B-cell lymphoma identifies a high-risk group of patients

Detalles Bibliográficos
Autores principales:	Ziepert, Marita, Lazzi, Stefano, Santi, Raffaella, Vergoni, Federica, Granai, Massimo, Mancini, Virginia, Staiger, Annette M., Horn, Heike, Löffler, Markus, Pöschel, Viola, Held, Gerhald, Wulf, Gerald, Trümper, Lorenz H., Schmitz, Norbert, Rosenwald, Andreas, Sabattini, Elena, Naresh, Kikkeri N., Stein, Harald, Ott, German, Leoncini, Lorenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2020
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604633/ https://www.ncbi.nlm.nih.gov/pubmed/33131258 http://dx.doi.org/10.3324/haematol.2019.235556

Ejemplares similares

IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications
por: Granai, Massimo, et al.
Publicado: (2019)

Age-dependent increase of treatment-related mortality in older patients with aggressive B cell lymphoma: analysis of outcome, treatment feasibility, and toxicity in 1171 elderly patients with aggressive B cell lymphoma—data from phase II and III trials of the DSHNHL (German High-Grade Non-Hodgkin’s Lymphoma Study Group)
por: Zettl, Florian, et al.
Publicado: (2020)

The impact of SOCS1 mutations in diffuse large B‐cell lymphoma
por: Mellert, Kevin, et al.
Publicado: (2019)

Molecular switch from MYC to MYCN expression in MYC protein negative Burkitt lymphoma cases
por: Mundo, Lucia, et al.
Publicado: (2019)

Burkitt lymphoma with a granulomatous reaction: an M1/Th1‐polarised microenvironment is associated with controlled growth and spontaneous regression
por: Granai, Massimo, et al.
Publicado: (2021)

Correction: Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas
por: Mundo, Lucia, et al.
Publicado: (2020)

Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas
por: Mundo, Lucia, et al.
Publicado: (2020)

Xanthomatous Inflammatory Infiltrate Involving the Spleen: An Unusual Presentation of Erdheim-Chester Disease and Review of the Literature
por: Di Stefano, Gioia, et al.
Publicado: (2021)

Low serum albumin is an independent risk factor in elderly patients with aggressive B‐cell lymphoma: Results from prospective trials of the German High‐Grade Non‐Hodgkin's Lymphoma Study Group
por: Hohloch, Karin, et al.
Publicado: (2020)

First-line Treatment With Bendamustine and Rituximab for Old and Frail Patients With Aggressive Lymphoma: Results of the B-R-ENDA Trial
por: Braulke, Friederike, et al.
Publicado: (2022)

Aggressive B-Cell Lymphomas
por: Naresh, Kikkeri N., et al.
Publicado: (2012)

Numerical and Structural Genomic Aberrations Are Reliably Detectable in Tissue Microarrays of Formalin-Fixed Paraffin-Embedded Tumor Samples by Fluorescence In-Situ Hybridization
por: Horn, Heike, et al.
Publicado: (2014)

Significant dose Escalation of Idarubicin in the treatment of aggressive Non- Hodgkin Lymphoma leads to increased hematotoxicity without improvement in efficacy in comparison to standard CHOEP-14: 9-year follow up results of the CIVEP trial of the DSHNHL
por: Hohloch, Karin, et al.
Publicado: (2014)

Epstein–Barr virus reactivation influences clonal evolution in human herpesvirus‐8‐related lymphoproliferative disorders
por: Granai, Massimo, et al.
Publicado: (2021)

Gene expression profiling reveals a close relationship between follicular lymphoma grade 3A and 3B, but distinct profiles of follicular lymphoma grade 1 and 2
por: Horn, Heike, et al.
Publicado: (2018)

Unusual presentation of extra-nodal double-hit follicular lymphoma: a case report
por: Lazzi, Stefano, et al.
Publicado: (2022)

Follicular Lymphoma in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms—Updated Classification and New Biological Data
por: Kurz, Katrin S., et al.
Publicado: (2023)

Distinct pattern of lymphoid neoplasms characterizations according to the WHO classification (2016) and prevalence of associated Epstein–Barr virus infection in Nigeria population
por: Uzoma, Ijeoma C., et al.
Publicado: (2021)

KMWin – A Convenient Tool for Graphical Presentation of Results from Kaplan-Meier Survival Time Analysis
por: Gross, Arnd, et al.
Publicado: (2012)

Central nervous system relapse in younger patients with diffuse large B-cell lymphoma: a LYSA and GLA/DSHNHL analysis
por: Thieblemont, Catherine, et al.
Publicado: (2023)

EBV persistence in gastric cancer cases conventionally classified as EBER-ISH negative
por: Siciliano, M. C., et al.
Publicado: (2022)

The Alteration of Lipid Metabolism in Burkitt Lymphoma Identifies a Novel Marker: Adipophilin
por: Ambrosio, Maria R., et al.
Publicado: (2012)

Large B-Cell Lymphomas in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms—Updated Classification and New Concepts
por: Kurz, Katrin S., et al.
Publicado: (2023)

FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials
por: Kaddu-Mulindwa, Dominic, et al.
Publicado: (2021)

Proposal of ‘reactive‐lymphocyte/histiocyte rich large B‐cell lymphoma’ as an alternate term for ‘nodular lymphocyte predominant Hodgkin lymphoma’ that would also address its overlap with T‐cell/histiocyte rich large B‐cell lymphoma
por: Naresh, Kikkeri N.
Publicado: (2022)

Gastrointestinal lymphoproliferative lesions: a practical diagnostic approach
por: Pizzi, Marco, et al.
Publicado: (2020)

Correction to: Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program
por: Granai, Massimo, et al.
Publicado: (2020)

Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program
por: Granai, Massimo, et al.
Publicado: (2020)

Metabolic Switch and Cytotoxic Effect of Metformin on Burkitt Lymphoma
por: Bagaloni, Irene, et al.
Publicado: (2021)

Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation
por: De Falco, Giulia, et al.
Publicado: (2015)

Radiation and Dose-densification of R-CHOP in Primary Mediastinal B-cell Lymphoma: Subgroup Analysis of the UNFOLDER Trial
por: Held, Gerhard, et al.
Publicado: (2023)

Pediatric autoimmune disorders with gastrointestinal expressions: from bench to bedside
por: Francalanci, Paola, et al.
Publicado: (2021)

Unveiling Another Missing Piece in EBV-Driven Lymphomagenesis: EBV-Encoded MicroRNAs Expression in EBER-Negative Burkitt Lymphoma Cases
por: Mundo, Lucia, et al.
Publicado: (2017)

Alteration of MicroRNAs Regulated by c-Myc in Burkitt Lymphoma
por: Onnis, Anna, et al.
Publicado: (2010)

Follicular lymphoma subgroups with and without t(14;18) differ in their N-glycosylation pattern and IGHV usage
por: Leich, Ellen, et al.
Publicado: (2021)

Impact of vincristine dose reduction on outcomes of patients with aggressive B-cell lymphoma treated with (R)-CHOP
por: Bewarder, Moritz, et al.
Publicado: (2023)

CHO(E)P-14 followed by alemtuzumab consolidation in untreated peripheral T cell lymphomas: final analysis of a prospective phase II trial
por: Binder, C., et al.
Publicado: (2013)

MiR-200c-3p Contrasts PD-L1 Induction by Combinatorial Therapies and Slows Proliferation of Epithelial Ovarian Cancer through Downregulation of β-Catenin and c-Myc
por: Anastasiadou, Eleni, et al.
Publicado: (2021)

A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit: A position paper from the Italian Group of Haematopathology (G.I.E.)
por: Di Napoli, Arianna, et al.
Publicado: (2019)

Posttransplant Lymphoproliferative Disorders
por: Ibrahim, Hazem A. H., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_becfed4j9pl4303e8enjpugr98